90 related articles for article (PubMed ID: 24791595)
21. Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.
Takeshita A; Shinjo K; Naito K; Matsui H; Sahara N; Shigeno K; Horii T; Shirai N; Maekawa M; Ohnishi K; Naoe T; Ohno R
Leukemia; 2005 Aug; 19(8):1306-11. PubMed ID: 15920495
[TBL] [Abstract][Full Text] [Related]
22. Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid.
Jiang G; Albihn A; Tang T; Tian Z; Henriksson M
Leuk Res; 2008 Feb; 32(2):297-307. PubMed ID: 17706770
[TBL] [Abstract][Full Text] [Related]
23. [Effect of arsenic trioxide on drug transporting molecules in acute promyelocytic leukemia cell line].
Qian XP; Liu BR; Yin HT; Wang LF; Zou ZY; Du J
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):601-5. PubMed ID: 15634520
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
[TBL] [Abstract][Full Text] [Related]
25. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells.
Mathieu J; Besançon F
Ann N Y Acad Sci; 2006 Dec; 1090():203-8. PubMed ID: 17384263
[TBL] [Abstract][Full Text] [Related]
27. [Expression change of IL-3 receptor system in all-trans retinoic acid induced differentiation of NB4 cells].
Wu Y; Yang JH; Li XF; Liao XY; Huang HF; Chen YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1474-8. PubMed ID: 21176354
[TBL] [Abstract][Full Text] [Related]
28. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3).
Zhang T; Westervelt P; Hess JL
Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
[TBL] [Abstract][Full Text] [Related]
30. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
Chen GQ; Zhou L; Styblo M; Walton F; Jing Y; Weinberg R; Chen Z; Waxman S
Cancer Res; 2003 Apr; 63(8):1853-9. PubMed ID: 12702573
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis.
Xia L; Wurmbach E; Waxman S; Jing Y
Leukemia; 2006 Jun; 20(6):1009-16. PubMed ID: 16572199
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.
Awwad RT; Do K; Stevenson H; Fu SW; Lo-Coco F; Costello M; Campbell CL; Berg PE
Ann Hematol; 2008 Mar; 87(3):195-203. PubMed ID: 18026954
[TBL] [Abstract][Full Text] [Related]
33. Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.
Tabellini G; Tazzari PL; Bortul R; Evangelisti C; Billi AM; Grafone T; Martinelli G; Baccarani M; Martelli AM
Br J Haematol; 2005 Sep; 130(5):716-25. PubMed ID: 16115127
[TBL] [Abstract][Full Text] [Related]
34. Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL.
Humbert M; Federzoni EA; Tschan MP
J Leukoc Biol; 2017 Dec; 102(6):1357-1370. PubMed ID: 28978663
[TBL] [Abstract][Full Text] [Related]
35. Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells.
Shibakura M; Niiya K; Niiya M; Asaumi N; Yoshida C; Nakata Y; Tanimoto M
Leuk Res; 2005 Jul; 29(7):755-9. PubMed ID: 15927671
[TBL] [Abstract][Full Text] [Related]
36. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report.
Bergstrom SK; Gillan E; Quinn JJ; Altman AJ
J Pediatr Hematol Oncol; 1998; 20(6):545-7. PubMed ID: 9856675
[TBL] [Abstract][Full Text] [Related]
37. Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells.
Leung J; Pang A; Yuen WH; Kwong YL; Tse EW
Blood; 2007 Jan; 109(2):740-6. PubMed ID: 16968895
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profile changes in NB4 cells induced by arsenic trioxide.
Wang HY; Liu SX; Zhang M
Acta Pharmacol Sin; 2003 Jul; 24(7):646-50. PubMed ID: 12852829
[TBL] [Abstract][Full Text] [Related]
39. Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway.
Roszak J; Smok-Pieniążek A; Nocuń M; Stępnik M
Chem Biol Interact; 2013 Oct; 205(3):198-211. PubMed ID: 23911876
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells.
Ramos AM; Fernández C; Amrán D; Sancho P; de Blas E; Aller P
Blood; 2005 May; 105(10):4013-20. PubMed ID: 15665116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
